Reply to Jacob and Colebunders
Clin Infect Dis
.
2018 Aug 31;67(6):985-986.
doi: 10.1093/cid/ciy250.
Authors
Susan S Ellenberg
1
,
Gerald T Keusch
2
,
Abdel G Babiker
3
,
Kathryn M Edwards
4
,
Roger J Lewis
5
,
Jens D Lundgren
6
,
Charles D Wells
7
,
Fred Wabwire-Mangen
8
,
Keith P W J McAdam
9
Affiliations
1
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
2
Departments of Medicine and Global Health, Boston University Schools of Medicine and Public Health, Massachusetts.
3
Medical Research Council Clinical Trials Unit, University College London, United Kingdom.
4
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee.
5
Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California.
6
Department of Infectious Diseases, University of Copenhagen, Denmark.
7
Infectious Diseases Unit, Sanofi-U.S., Bridgewater, New Jersey.
8
Department of Epidemiology, Makerere University School of Public Health, Kampala, Uganda.
9
Department of Clinical and Tropical Medicine, London School of Hygiene and Tropical Medicine, United Kingdom.
PMID:
29590323
DOI:
10.1093/cid/ciy250
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials as Topic
Emergencies*
Humans
Public Health*